Bora Pharmaceuticals Co., Ltd. announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through it…
Sanyou Biopharmaceutical Co., Ltd. and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. jointly announced the official signing of a strategic cooperation agreement. This partnership will focus on the co-development of novel radiopharmaceuticals and radiodiagnostic products, aiming to integrate their respecti…
Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, announced an agreement with Catalent Pharma Solutions ("Catalent") to acquire Catalent's facility in Nottingham, UK. The acquisition,…
Ipsen and Memo Therapeutics AG announced they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The anticipated acquisition is focused on potravitug, which is a Phase II clinical-stage antibody against the BK polyo…
Radnostix, Inc., a leader in radioisotope production and nuclear medicine solutions, announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA System technology platform, ELLEXA Explorer software and associated intellectual property. The product line was original…
AGC Biologics enters a strategic partnership with Pyramid Pharma Services. The collaboration combines AGC Biologics’ expertise in drug substance development and manufacturing with Pyramid’s sterile fill-finish capabilities, creating a differentiated U.S.-based offering and providing developers with a fully integrated …
Nona Biosciences, a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) dis…
Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. The collaboration is designed to identify clinically diffe…
Eurobio Scientific, a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, announces that it has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitutes the Lab Products division of CareDx, Inc., a…
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings Pte.Ltd., Singapore, have signed a Memorandum of Understanding (MoU) to establish a strategic Joint Venture aimed at expanding access to high-quality healthcare solutions across South-East Asia and selected intern…
Page 7 of 40